Capricor Therapeutics, Inc. ( CAPR) - Key Metrics
CAPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.62 | -$1,297.38 | -$1,338.50 |
| 2025Q3 | ? | -$0.54 | -$0.43 | -$0.52 |
| 2025Q2 | ? | -$0.57 | -$0.44 | -$0.47 |
| 2025Q1 | ? | -$0.53 | -$0.14 | -$0.17 |
CAPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -11.68 |
| 2025Q3 | ? | -3.35 |
| 2025Q2 | ? | -4.38 |
| 2025Q1 | ? | -4.44 |
CAPR
Price: $26.72
52 week price:
Earnings Per Share: -2.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 60100
Ebitda: -2.6 millionMarket Capitalization: 1.2 billion